Should I open or buy an Any Lab Test Now franchise in 2027?
Direct Answer
Yes for an operator who wants a lower-capital healthcare-services franchise riding the consumer-driven, direct-access lab-testing trend — Any Lab Test Now offers walk-in lab tests without a doctor visit, no insurance hassle. Any Lab Test Now, founded in 2007, franchises direct-access lab-testing centers where consumers (and employers) order blood tests, wellness panels, DNA/paternity tests, drug/alcohol screens, and more on a self-pay, walk-in basis — no doctor visit or insurance required.
The 2026 FDD lists a franchise fee around $35,000, total Item 7 investment of roughly $130,000 to $230,000 (lower than urgent care), a royalty near 7%, and a marketing fee. Mature centers gross $400,000-$1,000,000, with owners clearing $80,000-$220,000. Its edge is lower capital than urgent care, self-pay (no insurance billing) simplicity, B2B employer drug/wellness testing, and the consumer-health trend; the challenges are building consumer and employer demand and a (helpful) lab partnership model.
The Real Numbers
An Any Lab Test Now center leases 1,000-1,800 sq ft for a retail lab-testing storefront — consumers walk in, order tests directly (self-pay), get a sample drawn, and receive results (lab work done via partner labs). The self-pay model avoids insurance-billing complexity, and B2B employer testing (drug/wellness screens) adds revenue.
| Line Item | Low | High | Notes |
|---|---|---|---|
| Franchise fee | $35,000 | $35,000 | Per 2026 FDD |
| Buildout / leasehold | $50,000 | $110,000 | Retail/clinical fit-out |
| Equipment & technology | $30,000 | $70,000 | Draw stations, systems |
| Signage & decor | $12,000 | $35,000 | Brand-prescribed |
| Initial inventory/supplies | $8,000 | $22,000 | Phlebotomy supplies |
| Initial marketing | $12,000 | $35,000 | Consumer + B2B |
| Training & travel | $6,000 | $18,000 | Owner + staff |
| Working capital | $20,000 | $55,000 | First 3 months |
| Total Item 7 | ~$130,000 | ~$230,000 | Per 2026 FDD — lower |
| Royalty | ~7% of gross | ||
| Marketing fee | ~2% of gross |
Revenue reality: mature centers gross $400K-$1M across consumer self-pay tests (wellness panels, DNA, STD, allergy, etc.) and B2B employer testing (drug/alcohol/wellness screens). With phlebotomy/staff labor, lab-partner costs, rent, and royalty, owners clear $80K-$220K.
The self-pay model avoids insurance-billing complexity (simpler than urgent care), the lower capital improves return-on-investment, and B2B employer testing adds recurring revenue. The challenges are building consumer and employer demand and managing the lab-partnership model.
Who Wins With This Business
- Capital required: $130K-$230K, with $60,000-$110,000 liquid — lower than urgent care.
- Time commitment: business-hours operation.
- Skills: retail/healthcare operations, consumer marketing, and B2B (employer) sales.
- Geographic fit: population-dense markets with health-conscious consumers and employers.
- Lifestyle fit: hands-on, business-hours.
The winners are operators who build both consumer and B2B employer testing demand.
Who Loses With This Business
- Operators who can't build consumer/employer demand.
- Those weak at B2B (employer) sales.
- Markets with low health-conscious or employer demand.
- Weak-location centers.
- Those who underestimate marketing for awareness (consumer education needed).
2027 Market Conditions
- Demand: consumer-driven, direct-access health testing is growing — people want convenient, transparent, self-pay testing without doctor/insurance hassle.
- Self-pay simplicity: no insurance billing — simpler than urgent care/medical models.
- B2B testing: employer drug/wellness screens add recurring revenue.
- Lower capital: accessible healthcare-franchise entry.
- Competition: LabCorp/Quest retail, telehealth labs, and online test kits.
The 90-Day Decision Tree
- Day 1-15: Read the 2026 FDD and confirm the self-pay, direct-access model.
- Day 16-30: Interview 8+ owners; ask about consumer vs B2B mix, employer contracts, and net profit.
- Day 31-45: Validate a consumer-health and employer-dense market.
- Day 46-65: Secure a site and train staff (phlebotomy).
- Day 66-85: Build out and open the testing center.
- Drive consumer self-pay testing and B2B employer screens.
- Ongoing: build recurring employer-testing contracts.
Alternative Plays
- American Family Care / AFC — urgent care (higher capital, insurance-based).
- The DRIPBaR / IV-wellness — adjacent consumer-health franchises.
- Drug-testing/occupational-health businesses — adjacent B2B models.
- Restore Hyper Wellness / iCRYO — wellness franchises (in the Pulse library).
- Independent lab-testing business — full control, but no brand/lab partnerships.
- Other consumer-health franchises — adjacent models.
FAQ
What is direct-access lab testing?
Consumers order lab tests directly (self-pay, walk-in) without a doctor visit or insurance — blood tests, wellness panels, DNA/paternity, STD, allergy, drug/alcohol screens, and more. Any Lab Test Now provides the draw and results (via partner labs), giving consumers convenient, transparent, affordable testing without the medical-visit/insurance hassle.
It's a consumer-empowerment health model.
How much does an Any Lab Test Now owner make?
Owners clear $80,000-$220,000, on $400K-$1M gross, from consumer self-pay tests plus B2B employer testing. The lower capital and self-pay simplicity (no insurance billing) aid economics. Building consumer and employer demand drives the range.
Why is the self-pay model an advantage?
No insurance billing — consumers pay directly, avoiding the complexity, slow reimbursement, and compliance burden of insurance-based medical models (like urgent care). This simplifies operations and cash flow, lowers capital, and gives consumers transparent pricing. It's a simpler, more accessible healthcare-franchise model.
How important is B2B employer testing?
Significant — employer drug/alcohol/wellness screens provide recurring B2B revenue beyond consumer walk-ins. Operators who build employer contracts (workplace testing, DOT screens, wellness programs) add stable, repeat volume. This B2B side is a key driver of center profitability alongside consumer testing.
Is consumer health testing durable?
Yes — consumer-driven, direct-access health testing is a growing trend, as people seek convenient, transparent, self-pay testing and proactive health management. Combined with durable B2B employer testing, demand is solid. Competition (LabCorp/Quest retail, online kits) exists, so consumer marketing, B2B sales, and location matter.
Bottom Line
Open an Any Lab Test Now if you want a lower-capital ($130K-$230K) healthcare-services franchise riding the consumer-driven, direct-access lab-testing trend, with self-pay simplicity (no insurance billing), B2B employer-testing revenue, and you'll build consumer and employer demand. Its lower capital, self-pay simplicity, and B2B revenue are genuine strengths versus higher-capital medical franchises.
Skip it if you can't build consumer/employer demand, are weak at B2B sales, or are in a low-demand market. For operators wanting accessible healthcare-franchise entry, Any Lab Test Now offers a capital-efficient, dual-channel (consumer + B2B) testing franchise.
Sources
- Any Lab Test Now Franchise Disclosure Document (2026 filing) — Items 5, 6, 7, 19, 20
- Any Lab Test Now official franchise site — investment range and direct-access model
- Entrepreneur Franchise listings — Any Lab Test Now
- Franchise Business Review — healthcare-franchise satisfaction data
- IBISWorld — Diagnostic & Medical Laboratory Services in the US, 2026 industry report
- Statista — US consumer-health-testing and lab market, 2025-2026
- International Franchise Association (IFA) — 2027 Franchise Economic Outlook
- Consumer-directed health-testing and employer-testing market data 2026
- Workplace drug-testing market reports 2026
- US Census — population-density and employer demographic data, 2025-2026